Article
Mutational profiling of circulating tumor DNA and clinical characteristics in lymphoma: Based on next generation sequencing.
Molecular carcinogenesis - 1 Feb 2023
Hou Yue, Zi Jie, Liu Shuo, Ge Qinyu, Ge Zheng
Abstract excerpt
Liquid biopsy has been experimented with to identify the mutation of lymphoma based on next-generation sequencing (NGS). We applied NGS analysis to circulating tumor DNA (ctDNA) in 20 lymphoma patients. Then, we compared treatment outcomes, and clinical characteristics among these patients, then investigated mutational profiling. Two independent cohorts of 241 patients with mature B cell lymphoma in Mature B-cell...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
